KKR adds to Amedisys position

By
A A A

KKR adds to Amedisys position

Bobby Raines 11/22/2013

KKR Asset Management, already a beneficial owner of Amedisys ( AMED ) has been steadily adding to a position originally extablished last month. Most recently, KKR bought 425,515 share between Nov. 19 and Nov. 21. At prices between $14.39 and $14.77, KKR paid a total of $6,159,523 for the shares.

IK-> The technicals for AMED ($15.54 down $0.07) are bullish with an upward trend. Recent support has been around $14.13 and recent resistance has been around $15.89. Standard & Poor's does not follow the stock. Look at the March 10/12 bull-put spread for a 30-cent credit. That's an 17.65% return and the stock has to fall 22.8% to cause a problem.  [InvestorsKeyhole, Various news and data services]



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Originally published on InvestorsObserver.com


This article appears in: Investing , Options

Referenced Stocks: AMED

InvestorsObserver

InvestorsObserver

More from InvestorsObserver:

Related Videos

Stocks

Referenced

Most Active by Volume

112,007,213
  • $14.79 ▼ 2.12%
79,492,830
  • $17.05 ▲ 0.24%
63,236,947
  • $56.63 ▲ 7.54%
55,553,482
  • $3.41 ▼ 3.94%
53,662,885
  • $14.19 ▼ 3.47%
52,606,858
  • $100.75 ▲ 0.64%
39,074,810
  • $4.84 ▼ 2.22%
38,681,912
  • $25.62 ▲ 0.79%
As of 9/30/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com